DOES COVID-19 PANDEMIC AFFECT THE ELIMINATION OF TUBERCULOSIS? LESSONS LEARNED FROM INDONESIA
DOI:
https://doi.org/10.21010/Ajid%20v19i2.1Keywords:
Tuberculosis, tropical disease, infectious disease, East JavaAbstract
Background: Tuberculosis is one of the tropical diseases which still exist in the tropical country specifically Indonesia. This study aims to investigate the recent epidemiology of tuberculosis before and during the pandemic of COVID-19.
Materials and Methods: Data were collected from East Java Health Profile 2019 and 2020 which was provided by East Java Health Officer. Data were extracted and analyzed by statistical software SPSS and QGIS Application for the geographical map interpretation.
Results: This study shows that the total cases of tuberculosis in 2019 was 606,985 cases, while in 2020 was decreased to 384,752 cases. The incidence rate of tuberculosis in 2019 was 224.98 per 100,000 populations, while in 2020 was 134.58 per 100,000 populations. The province with the highest amount of tuberculosis in 2019 was West Java with 143,935 cases, and also in 2020 with 90,905 cases. The province with the lowest number of tuberculosis was North Kalimantan with 2,113 cases, while in 2020 were 985 cases. The highest incidence rate of tuberculosis in 2019 was found in Jakarta which was 443,47 per 100,000 population, while in 2020 was found in Papua which was 279.92 per 100,000 population. The lowest incidence rate in 2019 was found in Bali Province which was 102.72 per 100,000 population, while in 2020 was 67.43 per 100,000 population.
Conclusion: There was a decrease in TB cases before the COVID-19 pandemic (2019) compared to during the COVID-19 pandemic (2020).
References
Alene Addis Kefyalew, Wangdi Kinley and Clements Archie (2020). ““Impact of the COVID-19 Pandemic on Tuberculosis Control: An Overview,” Tropical Medicine of Infectious Disease., vol. 5, no. 123, p. 100032, doi: 10.1016/j.lanwpc.2020.100032
Caren Gabriella, Iskandar Deni, Pitaloka Dian, Abdullah Rizky and Suwantika Auliya (2022). “COVID-19 Pandemic Disruption on the Management of Tuberculosis Treatment in Indonesia,” Journal of Multidisciplinary Healthcare., vol. 15, no. January, pp. 175–183, 2022, doi: 10.2147/JMDH.S341130.
Cilloni Lucia, Fu Han, Vesga Juan, Dowdy David, Pretorius Carel, Ahmedov Sevim, (2020). “The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis,” E Clinical Medicine, vol. 28, no. March, p. 100603, 2020, doi: 10.1016/j.eclinm.2020.100603.
Daniel Promislow (2022). A geroscience perspective on COVID-19 mortality”, The journals of gerontology. Series A, Biological sciences and medical sciences, vol.17, no.75, p30-33, doi: 10.1093/gerona/glaa094
Dowdy W David (2022). “Has the COVID-19 pandemic increased tuberculosis mortality?,” Lancet Infectious Disease., vol. 22, no. 2, pp. 165–166.
Handayani Nurul, Megatsari Hario, Laksono Dwi Agung and Ibad Mursyidul (2021). “Performance Analysis of Pulmonary Tuberculosis Treatment in Indonesia,” Medico-Legal Update, vol.21, no.3
Hogan Alexandra, Jewell Britta, Smith Ellie Sherrard, Vesga Juan, Watson Oliver, Whittaker Charles, (2020). ““Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study,” Lancet Global Health., vol. 8, no. 9, pp. e1132–e1141, 2020, doi: 10.1016/S2214-109X(20)30288-6.
Indonesian Minsitry of Health (2020). “Performance report of the directorate general of disease prevention and control”. https://e-renggar.kemkes.go.id/file2018/e-performance/1-465827-3tahunan-768.pdf. 2020. [Online]. Available: https://e-renggar.kemkes.go.id/file2018/e-performance/1-465827-3tahunan-768.pdf
Khan Mishal, Rajal Benitez Joaquin, Bond Virginia, Fatima Kaneez Razia, Isani Khurshid Afshan, Sutherland Jayne, Kranzer Katharina (2021). “Mitigating the impact of COVID-19 on tuberculosis and HIV services: A cross-sectional survey of 669 health professionals in 64 low and middle-income countries,” PLoS One, vol. 16, no. 2 February, pp. 1–12, 2021, doi: 10.1371/journal.pone.0244936.
Kristini Tri, Hamidah Rana (2020). , “Potential Transmission of Pulmonary Tuberculosis to Family Members of Sufferers., Jurnal Kesehatan Masyarakat Indonesia, vol. 15, no. 1, p. 24, doi: 10.26714/jkmi.15.1.2020.24-28.
Lu Roujian, Zhao Xiang, Li Juan and Niu Peihua (2020). “Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding”, Lancet, vol. 395, no. 10224, pp. 565–574, 2020, doi: 10.1016/S0140-6736(20)30251-8.
Motta I, Centis R, Ambrosio LD, Garcia L, Goletti D, Guajano G, Lipani F, Palmieri F(2020). “Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts,” Pulmonology, vol. 26, no. 4, pp. 233–240, doi: 10.1016/j.pulmoe.2020.05.002.
Nikolayevskyy, Vladyslav, Yen Holicka, Dick van Soolingen, Marieke J. van der Werf, Csaba Ködmön, Elena Surkova, Doris Hillemann, Ramona Groenheit, and Daniela Cirillo (2021). "Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe." European Respiratory Journal 57, no. 1. doi: 10.1183/13993003.03890-2020.
Revita Tiara Christin Natalia, Makhfudli Makhfudli, Hasanuddin Hasanuddin, Sukartini Tintin, Acob Ugsang Rey Joel and Aini Nadhifatul Handira (2022). “The Impact of COVID-19 Pandemic on Tuberculosis Patient Treatment Adherence,” Jurnal Respirasi, vol. 8, no. 2, pp. 113–118, doi: 10.20473/jr.v8-i.2.2022.113-118.
Rodrigues, Aguiar, Migilori and Duarte (2022). ““Impact of the COVID-19 pandemic on tuberculosis services,” Pulmonology, vol. 28, no. 3, pp. 210–219, 2022, doi: 10.1016/j.pulmoe.2022.01.015.
The Global Fund (2021). “The Impact of Covid-19 on Hiv, Tb and Malaria Services and Systems for Health : a Snapshot From 502 Health Facilities”, Global Fund to Fight AIDS, Malaria, Tuberculosis, Online]. Available: https://reliefweb.int/sites/reliefweb.int/files/resources/covid-19_2020-disruption-impact_report_en.pdf
Utomo Budi, Chan Chow Khuen, Mertaniasih Ni Made, Soedarsono Soedarsono, Fauziyah Shifa, Sucipto Teguh Hari, Aquaresta Febriana, Eljatin Dwinka Syafira and Adnyana I Made Dwi Mertha (2022). “Comparison Epidemiology between Tuberculosis and COVID-19 in East Java Province, Indonesia: An Analysis of Regional Surveillance Data in 2020,” Tropical Medicine of Infectious Disease., vol. 7, no. 6, pp. 1–16, doi: 10.3390/tropicalmed7060083.
Visca D, Ong CWM, Tiberi S, Centis R, Ambrosio LD, Chen B and Mueller J (2021). “Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects,” Pulmonology, no. 2, March-April, pp. 151–165
World Health Organization (2020). “Coronavirus disease (COVID-2019) Situation Reports,” https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports (accessed May 29, 2020).
World Health Organization (2021). “Global Tuberculosis Report 2020”, doi: 10.1016/S0140-6736(00)58733-9.
World Health Organization (2019). “Implementing Tuberculosis Policy Framework”, Tuberculosis Policy Framework, vol.4, no.7, pp. 1-47.
World Health Organization (2020). “Tuberculosis and COVID-19: Considerations for tuberculosis care,” World Heal. Organ., no. May, p. 11. Available: https://www.who.int/docs/default-source/documents/tuberculosis/infonote-tb-covid-19.pdf
World Health Organization (2019). “Global Tuberculosis Report 2018”. vol. 63, no. 10. France: World Health Organisation., 2018. [Online]. Available: https://apps.who.int/iris/handle/10665/274453
World Health Organization (2019). “Global Tuberculosis Report 2019”. France: World Health Organisation., 2019. [Online]. Available: https://www.who.int/tb/publications/global_report/en/
Zhou Fei, Yu Ting, Du Ronghui, Fan Guohui, Liu Ying and Liu Zhibo (2020). "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study," Lancet, vol. 395, no. 10229, pp. 1054-1062, 2020, doi: 10.1016/S0140-6736(20)30566-3.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 African Journal of Infectious Diseases (AJID)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright: Creative Commons Attribution CC BY This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. View License Deed | View Legal Code Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications.